Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.099 | 0.07 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |